Nuveen Asset Management, LLC Syros Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $126,444 - $221,736	-183,253 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.02 - $3.8 $2,718 - $10,127	2,665 Added 1.48%	183,253 $202,000
Q4 2021 Feb 14, 2022	SELL	$3.26 - $4.66 $58,647 - $83,833	-17,990 Reduced 9.06%	180,588 $611,000
Q3 2021 Nov 12, 2021	BUY	$4.08 - $5.66 $73,701 - $102,242	18,064 Added 10.01%	198,578 $1.01 Million
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $169,844 - $253,579	33,901 Added 23.12%	180,514 $984,000
Q1 2021 May 17, 2021	BUY	$7.19 - $14.95 $15,825 - $32,904	2,201 Added 1.52%	146,613 $1.1 Million
Q4 2020 Feb 16, 2021	SELL	$6.66 - $14.66 $244,708 - $538,652	-36,743 Reduced 20.28%	144,412 $1.57 Million
Q3 2020 Nov 16, 2020	SELL	$8.69 - $14.47 $192,370 - $320,322	-22,137 Reduced 10.89%	181,155 $1.6 Million
Q2 2020 Aug 14, 2020	BUY	$5.21 - $11.03 $336,894 - $713,232	64,663 Added 46.64%	203,292 $2.17 Million
Q1 2020 May 14, 2020	SELL	$4.46 - $9.2 $8,911 - $18,381	-1,998 Reduced 1.42%	138,629 $822,000
Q4 2019 Feb 14, 2020	BUY	$4.52 - $10.1 $149,105 - $333,178	32,988 Added 30.65%	140,627 $972,000
Q3 2019 Nov 14, 2019	SELL	$7.14 - $11.65 $31,137 - $50,805	-4,361 Reduced 3.89%	107,639 $1.12 Million
Q2 2019 Aug 15, 2019	BUY	$5.5 - $9.75 $616,000 - $1.09 Million	112,000 New	112,000 $1.04 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.